Urgent

Pertussis (whooping cough)

Bordetella · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Bordetella pertussis — paroxysmal coughing fits with an inspiratory "whoop", post-tussive vomiting, and apnoea in infants. Macrolides mainly reduce transmission (limited effect once paroxysms are established). Most dangerous in young infants.

Red flags

  • Infant apnoea, cyanosis or poor feeding
  • Respiratory distress
  • Seizures / encephalopathy
  • Pneumonia

Assessment

Differential diagnosis

  • Viral URTI / bronchiolitis
  • Asthma
  • Inhaled foreign body
  • Mycoplasma
  • Croup
  • GORD

Investigations

  • Nasopharyngeal swab PCR (or culture) for B. pertussis
  • Pertussis serology (later disease)
  • FBC (lymphocytosis); CXR if respiratory distress
  • Notify public health

Management

  • Suspect with paroxysmal cough > 2 weeks, whoop, post-tussive vomiting, or infant apnoea
  • Macrolide antibiotic — give early (catarrhal phase) to reduce transmission
  • Admit young infants (apnoea, feeding difficulty, cyanosis) — monitor with supportive oxygen / feeding
  • Antibiotic prophylaxis for vulnerable close contacts; ensure vaccination (incl. maternal pertussis vaccine)
  • Notify public health; exclude until 48 h of antibiotics (or 21 days from cough onset)

Drugs & doses

Azithromycin
Clarithromycin
Co-trimoxazole (alt)

Disposition

Admit young infants and any respiratory compromise. Otherwise home with a macrolide, exclusion and contact management. Notifiable.

Complications & pitfalls

  • Apnoea (infants)
  • Secondary pneumonia
  • Seizures / encephalopathy
  • Rib fracture, pneumothorax or syncope from coughing

Exam pearls

  • Antibiotics mainly reduce transmission — symptoms persist (the "100-day cough")
  • Young infants are at highest risk — low threshold to admit
  • Maternal pertussis vaccination protects newborns
  • Notify and give contact prophylaxis to vulnerable contacts

Treat early with a macrolide (mainly to cut transmission), admit at-risk infants for apnoea monitoring, and notify with contact prophylaxis.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.